Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Intangibles (2021 - 2025)

LifeStance Health (LFST) has disclosed Intangibles for 5 consecutive years, with $177.7 million as the latest value for Q4 2025.

  • Quarterly Intangibles fell 6.88% to $177.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $177.7 million through Dec 2025, down 6.88% year-over-year, with the annual reading at $177.7 million for FY2025, 6.88% down from the prior year.
  • Intangibles for Q4 2025 was $177.7 million at LifeStance Health, down from $180.8 million in the prior quarter.
  • The five-year high for Intangibles was $316.5 million in Q2 2021, with the low at $177.7 million in Q4 2025.
  • Average Intangibles over 5 years is $237.4 million, with a median of $233.6 million recorded in 2023.
  • The sharpest move saw Intangibles fell 17.94% in 2024, then dropped 6.88% in 2025.
  • Over 5 years, Intangibles stood at $300.4 million in 2021, then dropped by 12.34% to $263.3 million in 2022, then fell by 16.04% to $221.1 million in 2023, then decreased by 13.69% to $190.8 million in 2024, then decreased by 6.88% to $177.7 million in 2025.
  • According to Business Quant data, Intangibles over the past three periods came in at $177.7 million, $180.8 million, and $184.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.